Sarepta Therapeutics Inc (SRPT) USD0.0001
1.26%- This stock can be held in a
Stocks and Shares ISASell:$59.01
Buy:$66.75
Change:
$1.32
(2.14%)
$1.32
(2.14%)Market closed | Prices delayed by at least 15 minutes
Sell:$59.01
Buy:$66.75
Change:$1.32
(2.14%)
$1.32
(2.14%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 12 March 2025 | Claude NicaiseDirector | Sell Option/Award related | 2,491 | $99.64 | $248,203.24 | 27,812 |
| 10 March 2025 | Louise Rodino-KlapacChief Level Officer | Sell Tax related | 924 | $100.13 | $92,520.12 | 78,894 |
| 10 March 2025 | Louise Rodino-KlapacChief Level Officer | Sell Tax related | 2,539 | $100.13 | $254,230.07 | 76,355 |
| 10 March 2025 | Ian Michael EstepanCFO | Sell Tax related | 1,051 | $100.13 | $105,236.63 | 57,226 |
| 10 March 2025 | Ian Michael EstepanCFO | Sell Tax related | 2,890 | $100.13 | $289,375.70 | 54,336 |
| 10 March 2025 | Dallan MurrayChief Level Officer | Sell Tax related | 996 | $100.13 | $99,729.48 | 32,663 |
| 10 March 2025 | Dallan MurrayChief Level Officer | Sell Tax related | 2,737 | $100.13 | $274,055.81 | 29,926 |
| 10 March 2025 | Bilal ArifCTO | Sell Tax related | 523 | $100.13 | $52,367.99 | 24,224 |
| 10 March 2025 | Cristin (Cris) RothfussExecutive Vice President | Sell Tax related | 491 | $100.13 | $49,163.83 | 12,834 |
| 7 March 2025 | Louise Rodino-KlapacChief Level Officer | Sell Tax related | 514 | $103.70 | $53,301.80 | 82,308 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 25 June 2024 | Ryan Edward BrownGeneral Counsel | Sell Regular sell transaction (market) | 17,581 | $162.65 | $2,859,549.65 | 23,518 |
| 16 August 2024 | Michael Andrew ChambersIndependent Director | Buy Regular purchase transaction | 18,284 | $134.06 | $2,451,153.04 | 278,386 |
| 16 August 2024 | Michael Andrew ChambersIndependent Director | Buy Regular purchase transaction | 13,106 | $133.07 | $1,744,015.42 | 260,102 |
| 12 December 2024 | Hans Lennart Rudolf WigzellIndependent Director | Sell Option/Award related | 10,500 | $124.84 | $1,310,820.00 | 22,840 |
| 25 June 2024 | Ryan Edward BrownGeneral Counsel | Sell Option/Award related | 7,644 | $158.07 | $1,208,287.08 | 48,442 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.